0000874716-24-000007.txt : 20240105 0000874716-24-000007.hdr.sgml : 20240105 20240105170213 ACCESSION NUMBER: 0000874716-24-000007 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreck Michael CENTRAL INDEX KEY: 0002004990 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 24517389 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 3 1 wk-form3_1704492123.xml FORM 3 X0206 3 2024-01-01 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0002004990 Schreck Michael ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President Common Stock 535 D Restricted Stock Unit Common Stock 164 D Restricted Stock Unit Common Stock 160 D Restricted Stock Unit Common Stock 352 D Restricted Stock Unit Common Stock 791 D Restricted Stock Unit Common Stock 678 D Restricted Stock Unit Common Stock 1005 D Incentive Stock Option (right-to-buy) 398.49 2030-08-31 Common Stock 744 D Non-Qualified Stock Option (right-to-buy) 544.08 2031-02-13 Common Stock 2769 D Incentive Stock Option (right-to-buy) 544.08 2031-02-13 Common Stock 324 D Non-Qualified Stock Option (right-to-buy) 505.53 2032-02-13 Common Stock 3952 D Incentive Stock Option (right-to-buy) 505.53 2032-02-13 Common Stock 197 D Non-Qualified Stock Option (right-to-buy) 497.43 2033-02-13 Common Stock 4765 D Incentive Stock Option (right-to-buy) 497.43 2033-02-13 Common Stock 201 D Grant of 659 restricted stock units ('RSU'). Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on September 1, 2021. Grant of 322 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2022. Grant of 470 RSUs. Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2023. Grant of 791 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on February 14, 2025. Grant of 678 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024. Grant of 1,005 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on February 14, 2026. Grant of option to buy 744 shares of Issuer common stock that vests in four annual installments beginning on September 1, 2021. Grant of option to buy 2,769 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2022. Grant of option to buy 324 shares of Issuer common stock that vests in one installment on February 14, 2025. Grant of option to buy 3,952 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2023. Grant of option to buy 197 shares of Issuer common stock that vests in one installment on February 14, 2026. Grant of option to buy 4,765 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2024. Grant of option to buy 201 shares of Issuer common stock that vests in one installment on February 14, 2027. /s/ Michael Schreck 2024-01-05 EX-24.1 2 ex241-schreckpoa.htm EX-24.1 Document

Exhibit 24.1

POWER OF ATTORNEY
For Executing Form ID and Forms 3, 4 and 5

Know all by these presents, that the undersigned hereby constitutes and appoints each of Sharon E. Underberg, Lily J. Lu and Brenton N. Speed or any of them signing singly, and with full power of substitution, the undersigned’s true and lawful attorney‑in‑fact to:

(1) prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

(2) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer of IDEXX Laboratories, Inc. (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and

(4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney‑in‑fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney‑in‑fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney‑in‑fact may approve in such attorney‑in‑fact’s discretion.

The undersigned hereby grants to each such attorney‑in‑fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney‑in‑fact, or such attorney‑in‑fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys‑in‑fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys‑in‑fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 15th day of December 2023.

/s/ Michael Schreck
Signature

Michael Schreck